Cohen & Steers Toekomstige groei
Future criteriumcontroles 2/6
Cohen & Steers is forecast to grow earnings and revenue by 13.8% and 8.8% per annum respectively. EPS is expected to grow by 14.1% per annum. Return on equity is forecast to be 38.1% in 3 years.
Belangrijke informatie
13.8%
Groei van de winst
14.1%
Groei van de winst per aandeel
Capital Markets winstgroei | 14.3% |
Inkomstengroei | 8.8% |
Toekomstig rendement op eigen vermogen | 38.1% |
Dekking van analisten | Low |
Laatst bijgewerkt | 18 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Some Shareholders Feeling Restless Over Cohen & Steers, Inc.'s (NYSE:CNS) P/E Ratio
Oct 17Cohen & Steers: Still Bullish After Assessing Q2 Results And AUM Figures
Jul 18Cohen & Steers, Inc.'s (NYSE:CNS) Shares May Have Run Too Fast Too Soon
Jul 16Cohen & Steers: Eyes On Real Estate Recovery And Overseas Markets Growth
May 02Shareholders Will Most Likely Find Cohen & Steers, Inc.'s (NYSE:CNS) CEO Compensation Acceptable
Apr 26Cohen & Steers, Inc.'s (NYSE:CNS) Share Price Not Quite Adding Up
Apr 01Cohen & Steers: Dependence On Real Estate, Still Not Buying It
Feb 16Getting In Cheap On Cohen & Steers, Inc. (NYSE:CNS) Is Unlikely
Dec 19Cohen & Steers: The Issue Is Real Estate
Nov 28Cohen & Steers: Focus On Asia Expansion And Cost Management (Rating Upgrade)
Sep 10Cohen & Steers: It's All About Real Estate
Jun 27Cohen & Steers AUM up 8.5% in January on net inflows, market appreciation
Feb 08Cohen & Steers: Best Near-Term Investment Management Capital Gain Prospect
Feb 03Cohen & Steers AUM down 4.5% sequentially in December on market depreciation
Jan 10Cohen & Steers AUM rises to $84.2B in November on market appreciation
Dec 08Cohen & Steers reports prelim AUM for Oct
Nov 08The Cohen & Steers, Inc. (NYSE:CNS) Analyst Just Cut Their Revenue Forecast By 15%
Oct 20Cohen & Steers Q3 2022 Earnings Preview
Oct 18Cohen & Steers AUM falls to $79.2B on market depreciation, net outflows
Oct 10Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 656 | 209 | 195 | N/A | 2 |
12/31/2025 | 610 | 184 | 155 | N/A | 2 |
12/31/2024 | 523 | 147 | 112 | N/A | 2 |
9/30/2024 | 497 | 135 | N/A | N/A | N/A |
6/30/2024 | 487 | 128 | 124 | 169 | N/A |
3/31/2024 | 486 | 128 | 135 | 192 | N/A |
12/31/2023 | 490 | 129 | 115 | 172 | N/A |
9/30/2023 | 496 | 132 | 124 | 171 | N/A |
6/30/2023 | 512 | 144 | 126 | 149 | N/A |
3/31/2023 | 539 | 164 | 145 | 153 | N/A |
12/31/2022 | 567 | 171 | 57 | 62 | N/A |
9/30/2022 | 601 | 203 | 72 | 76 | N/A |
6/30/2022 | 615 | 210 | 101 | 104 | N/A |
3/31/2022 | 612 | 205 | 125 | 128 | N/A |
12/31/2021 | 584 | 211 | 240 | 243 | N/A |
9/30/2021 | 541 | 143 | 171 | 173 | N/A |
6/30/2021 | 498 | 123 | 122 | 124 | N/A |
3/31/2021 | 447 | 105 | 102 | 104 | N/A |
12/31/2020 | 428 | 77 | 87 | 89 | N/A |
9/30/2020 | 421 | 118 | 152 | 155 | N/A |
6/30/2020 | 415 | 120 | 148 | 151 | N/A |
3/31/2020 | 422 | 123 | 163 | 165 | N/A |
12/31/2019 | 411 | 135 | 139 | 141 | N/A |
9/30/2019 | 395 | 123 | 104 | 107 | N/A |
6/30/2019 | 388 | 120 | 109 | 112 | N/A |
3/31/2019 | 381 | 119 | 69 | 72 | N/A |
12/31/2018 | 381 | 114 | 69 | 73 | N/A |
9/30/2018 | 387 | 109 | 90 | 93 | N/A |
6/30/2018 | 385 | 103 | N/A | 92 | N/A |
3/31/2018 | 383 | 97 | N/A | 37 | N/A |
12/31/2017 | 379 | 92 | N/A | 64 | N/A |
9/30/2017 | 369 | 98 | N/A | 65 | N/A |
6/30/2017 | 366 | 97 | N/A | 63 | N/A |
3/31/2017 | 360 | 98 | N/A | 116 | N/A |
12/31/2016 | 351 | 93 | N/A | 115 | N/A |
9/30/2016 | 342 | 79 | N/A | 82 | N/A |
6/30/2016 | 327 | 68 | N/A | 84 | N/A |
3/31/2016 | 325 | 62 | N/A | 87 | N/A |
12/31/2015 | 329 | 65 | N/A | 90 | N/A |
9/30/2015 | 329 | 68 | N/A | 104 | N/A |
6/30/2015 | 330 | 74 | N/A | 88 | N/A |
3/31/2015 | 325 | 77 | N/A | 55 | N/A |
12/31/2014 | 314 | 76 | N/A | 55 | N/A |
9/30/2014 | 306 | 79 | N/A | 54 | N/A |
6/30/2014 | 299 | 79 | N/A | 79 | N/A |
3/31/2014 | 298 | 72 | N/A | 102 | N/A |
12/31/2013 | 298 | 68 | N/A | 76 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: CNS's forecast earnings growth (13.8% per year) is above the savings rate (2.5%).
Winst versus markt: CNS's earnings (13.8% per year) are forecast to grow slower than the US market (15.4% per year).
Hoge groeiwinsten: CNS's earnings are forecast to grow, but not significantly.
Omzet versus markt: CNS's revenue (8.8% per year) is forecast to grow slower than the US market (8.9% per year).
Hoge groei-inkomsten: CNS's revenue (8.8% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: CNS's Return on Equity is forecast to be high in 3 years time (38.1%)